Found 22 matching trials
A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery Disease PHASE2 A single center, double-blind, placebo-controlled, randomized, crossover, p...
Show More Location
Multiple Locations
Learn More & Join Trial
A Pharmacokinetics Study of Aleglitazar in Combination With Digoxin in Healthy Volunteers PHASE1 This open-label, two-period, fixed-sequence study will investigate the phar...
Show More Location
Multiple Locations
Learn More & Join Trial
A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With Lisinopril PHASE1 This randomized, double-blind, placebo-controlled, parallel-group study wil...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of The Effect of Hepatic Impairment on The Pharmacokinetics of Aleglitazar PHASE1 This open-label study will assess the effects of hepatic impairment on the ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of The Effect of Aleglitazar on Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin PHASE2 This single-center, randomized, double-blind, placebo-controlled study will...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Alone PHASE3 This multicenter, randomized, double-blind, placebo-controlled study will a...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy PHASE3 This multicenter, randomized, double-blind, placebo-controlled study will a...
Show More Location
Multiple Locations
Learn More & Join Trial
A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and New York Heart Association (NYHA) Class II Heart Failure. PHASE2 This 2 arm study will compare the safety, tolerability and efficacy of aleg...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Investigate the Effects of Rifampicin on the Pharmacokinetics of Aleglitazar in Healthy Volunteers PHASE1 This open-label, fixed-sequence, three-period, single group study will eval...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities PHASE3 This randomized, double-blind, placebo-controlled, parallel group, multicen...
Show More Location
Multiple Locations
Learn More & Join Trial